SCHEMBL4716775

SCHEMBL4716775

CC(C)[N+]1(C(=O)c2cccc(N3Cc4cccc(Cl)c4C3=O)c2)CCC(C2CCNCC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.47
BDKRB1 P46663 1/20 0.45
NR1H4 Q96RI1 3/20 0.38
HTR2A P28223 3/20 0.38
HTR2C P28335 3/20 0.38
HTR2B P41595 3/20 0.38
GRM1 Q13255 4/20 0.37
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KMT2A Q03164 1/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4711834 0.88 BDKRB1 (0.49) PARP1BDKRB1NR1H4HTR2AHTR2C
SCHEMBL4714982 0.84 PARP1 (0.39) PARP1BDKRB1HTR2AHTR2CHTR2B
SCHEMBL4714835 0.82 BDKRB1 (0.60) PARP1BDKRB1HTR2AHTR2CHTR2B
SCHEMBL5629725 0.80 PARP1 (0.46) PARP1BDKRB1NR1H4HTR2AHTR2C
SCHEMBL4715045 0.79 PARP1 (0.47) PARP1BDKRB1NR1H4HTR2AHTR2C
SCHEMBL4717373 0.78 BDKRB1 (0.53) PARP1BDKRB1NR1H4HTR2AHTR2C
SCHEMBL4716174 0.77 BDKRB1 (0.42) PARP1BDKRB1NR1H4HTR2AHTR2C
SCHEMBL5628754 0.76 BDKRB1 (0.57) PARP1BDKRB1NR1H4HTR2AHTR2C
SCHEMBL4717586 0.75 BDKRB1 (0.56) PARP1BDKRB1HTR2AHTR2CHTR2B
SCHEMBL5630639 0.75 BDKRB1 (0.61) PARP1BDKRB1HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1877401-A2 NOVEL COMPOUNDS USEFUL FOR BRADYKININ B1 RECEPTOR ANTAGONISM Elan Pharmaceuticals Inc. (US) 2008-01-16 EP disclosed
WO-2006113140-A2 NOVEL COMPOUNDS USEFUL FOR BRADYKININ B1 RECEPTOR ANTAGONISM ELAN PHARMACEUTICALS, INC. (US) 2006-10-26 WO disclosed